Age-related cerebral white matter disease (Leukoaraiosis): A review

Postgraduate Medical Journal

Volumn 88, Issue 1036, 2012, Pages 79-87

  Grueter, Basil E ^a   Schulz, Ursula G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; HOMOCYSTEINE;

AGING; ANTICOAGULATION; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOT LYSIS; BLOOD PRESSURE REGULATION; CAUCASIAN; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CYANOCOBALAMIN DEFICIENCY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DYSLIPOPROTEINEMIA; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LEUKOARAIOSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PROGNOSIS; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; SMOKING; STAGING; STROKE; SUSCEPTIBILITY WEIGHTED IMAGING; WHITE MATTER;

AGE FACTORS; CEREBRAL SMALL VESSEL DISEASES; HUMANS; HYPERTENSION; LEUKOARAIOSIS; MAGNETIC RESONANCE IMAGING; NEUROIMAGING; RISK FACTORS;

EID: 84856021257     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/postgradmedj-2011-130307     Document Type: Article

References (90)

1. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010; 341: c3666.
2. Binswanger O. Die Abgrenzung der allgemeinen progressiven Paralyse. Berl Klin Wochenschr 1894; 31: 1180-6.
3. Alzheimer A. Die Seelenstörung auf arteriosklerotischer Grundlage. Allg Z Psychiat 1902; 59: 695-701.
4. Hachinski VC, Potter P, Merskey H. Leuko-araiosis. Arch Neurol 1987; 44: 21-3.
5. Grinberg LT, Thal DR. Vascular pathology in the aged human brain. Acta Neuropathol 2010; 119: 277-90.
6. Knottnerus ILH, Ten Cate H, Lodder J, et al. Endothelial dysfunction in lacunar stroke: a systematic review. Cerebrovasc Dis 2009; 27: 519-26.
7. Stevenson SF, Doubal FN, Shuler K, et al. A systematic review of dynamic cerebral and peripheral endothelial function in lacunar stroke versus controls. Stroke 2010; 41: 434-42.
8. Topakian R, Barrick TR, Howe FA, et al. Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis. J Neurol Neurosurg Psychiatry 2010; 81: 192-7.
9. Jickling G, Salam A, Mohammad A, et al. Circulating endothelial progenitor cells and age-related white matter changes. Stroke 2009; 40: 3191-6.
10. Baune BT, Ponath G, Rothermundt M, et al. Association between cytokines and cerebral MRI changes in the aging brain. J Geriatr Psychiatry Neurol 2009; 22: 23-34.
11. Wardlaw JM, Doubal F, Armitage P, et al. Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. Ann Neurol 2009; 65: 194-202.
12. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke 1997; 28: 652-9.
13. Black S, Gao F, Bilbao J. Understanding white matter disease: imaging-pathological correlations in vascular cognitive impairment. Stroke 2009; 40: S48-52.
14. Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993; 43: 1683-9.
15. Fernando MS, Simpson JE, Matthews F, et al. White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 2006; 37: 1391-8.
16. Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. Stroke 1995; 26: 1293-301.
17. Fisher CM. Lacunar infarctsda review. Cerebrovasc Dis 1991; 1: 311-20.
18. Khan U, Porteous L, Hassan A, et al. Risk factor profile of cerebral small vessel disease and its subtypes. J Neurol Neurosurg Psychiatry 2007; 78: 702-6.
19. Lammie AG. Pathology & genetics. cerebrovascular diseases. In: Kalimo H, ed. Pathology & Genetics. Cerebrovascular Diseases. Basel: ISN Neuropath Press, 2005: 85-91.
20. Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 2009; 8: 165-74.
21. Jeong JH, Yoon SJ, Kang SJ, et al. Hypertensive pontine microhemorrhage. Stroke 2002; 33: 925-9.
22. Longstreth WT Jr, Manolio TA, Arnold A, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996; 27: 1274-82.
23. Breteler MM, van Amerongen NM, van Swieten JC, et al. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study. Stroke 1994; 25: 1109-15.
24. Appelman AP, Vincken KL, van der Graaf Y, et al. White matter lesions and lacunar infarcts are independently and differently associated with brain atrophy: the SMARTMR study. Cerebrovasc Dis 2010; 29: 28-35.
25. Wahlund LO, Barkhof F, Fazekas F, et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001; 32: 1318-22.
26. van Den Boom R, Lesnik Oberstein SA, van Duinen SG, et al. Subcortical lacunar lesions: an MR imaging finding in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Radiology 2002; 224: 791-6.
27. O'Sullivan M, Jarosz JM, Martin RJ, et al. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology 2001; 56: 628-34.
28. van Swieten JC, Hijdra A, Koudstaal PJ, et al. Grading white matter lesions on CT and MRI: a simple scale. J Neurol Neurosurg Psychiatry 1990; 53: 1080-3.
29. Scheltens P, Erkinjunti T, Leys D, et al. White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes. Eur Neurol 1998; 39: 80-9.
30. Hopkins RO, Beck CJ, Burnett DL, et al. Prevalence of white matter hyperintensities in a young healthy population. J Neuroimaging 2006; 16: 243-51.
31. de Leeuw FE, de Groot JC, Achten E, et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001; 70: 9-14.
32. Longstreth WT Jr. Brain abnormalities in the elderly: frequency and predictors in the United States (the Cardiovascular Health Study). Cardiovascular Health Study Collaborative Research Group. J Neural Transm Suppl 1998; 53: 9-16.
33. Dufouil C, de Kersaint-Gilly A, Besancon V, et al. Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology 2001; 56: 921-6.
34. Breteler MM, van Swieten JC, Bots ML, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994; 44: 1246-52.
35. Gao T, Wang Y, Zhang Z. Silent cerebral microbleeds on susceptibility-weighted imaging of patients with ischemic stroke and leukoaraiosis. Neurol Res 2008; 30: 272-6.
36. Park K, Yasuda N, Toyonaga S, et al. Significant association between leukoaraiosis and metabolic syndrome in healthy subjects. Neurology 2007; 69: 974-8.
37. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 2004; 109: 1101-7.
38. Lovelock CE, Molyneux AJ, Rothwell PM. Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a populationbased study. Lancet Neurol 2007; 6: 487-93.
39. Padovani A, Di Piero V, Bragoni M, et al. Correlates of leukoaraiosis and ventricular enlargement on magnetic resonance imaging: a study in normal elderly and cerebrovascular patients. Eur J Neurol 1997; 4: 15-23.
40. Streifler JY, Eliasziw M, Benavente OR, et al. Lack of relationship between leukoaraiosis and carotid artery disease. The North American Symptomatic Carotid Endarterectomy Trial. Arch Neurol 1995; 52: 21-4.
41. Srikanth V, Beare R, Blizzard L, et al. Cerebral white matter lesions, gait, and the risk of incident falls: a prospective population-based study. Stroke 2009; 40: 175-80.
42. van Dijk EJ, Prins ND, Vrooman HA, et al. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke 2008; 39: 2712-19.
43. Simoni M, Mehta Z, Rothwell PM. Validity of CT versus MR brain imaging in studies of risk factors for Leukoaraiosis: a systematic review. Cerebrovasc Dis 2010; 29(Suppl 2): 300.
44. Gottesman RF, Coresh J, Catellier DJ, et al. Blood pressure and white-matter disease progression in a biethnic cohort: Atherosclerosis Risk in Communities (ARIC) study. Stroke 2010; 41: 3-8.
45. Meadows TA, Bhatt DL, Hirsch AT, et al. Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) registry. Am Heart J 2009; 158: 1038-45.
46. Birns J, Jarosz J, Markus HS, et al. Cerebrovascular reactivity and dynamic autoregulation in ischaemic subcortical white matter disease. J Neurol Neurosurg Psychiatry 2009; 80: 1093-8.
47. Bokura H, Yamaguchi S, Iijima K, et al. Metabolic syndrome is associated with silent ischemic brain lesions. Stroke 2008; 39: 1607-9.
48. Anan F, Masaki T, Eto T, et al. Visceral fat accumulation is a significant risk factor for white matter lesions in Japanese type 2 diabetic patients. Eur J Clin Invest 2009; 39: 368-74.
49. Bogousslavsky J, Regli F, Uske A. Leukoencephalopathy in patients with ischemic stroke. Stroke 1987; 18: 896-9.
50. Koçer A, Esen O, Ince N, et al. Heart failure with low cardiac output and risk of development of lesions in the cerebral white matter. Eur Gen Med 2005; 2: 56-61.
51. Ohmine T, Miwa Y, Yao H, et al. Association between arterial stiffness and cerebral white matter lesions in community-dwelling elderly subjects. Hypertens Res 2008; 31: 75-81.
52. Manolio TA, Burke GL, O'Leary DH, et al. Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults: the Cardiovascular Health Study. CHS Collaborative Research Group. Arterioscler Thromb Vasc Biol 1999; 19: 356-65.
53. Ikram MA, van Oijen M, de Jong FJ, et al. Unrecognized myocardial infarction in relation to risk of dementia and cerebral small vessel disease. Stroke 2008; 39: 1421-6.
54. Lindgren A, Roijer A, Rudling O, et al. Cerebral lesions on magnetic resonance imaging, heart disease, and vascular risk factors in subjects without stroke. A population-based study. Stroke 1994; 25: 929-34.
55. de Lau LM, Smith AD, Refsum H, et al. Plasma vitamin B12 status and cerebral white-matter lesions. J Neurol Neurosurg Psychiatry 2009; 80: 149-57.
56. Pieters B, Staals J, Knottnerus I, et al. Periventricular white matter lucencies relate to low vitamin B12 levels in patients with small vessel stroke. Stroke 2009; 40: 1623-6.
57. Wright CB, Paik MC, Brown TR, et al. Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study. Stroke 2005; 36: 1207-11.
58. Hassan A, Hunt BJ, O'Sullivan M, et al. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 2004; 127: 212-19.
59. Carmelli D, DeCarli C, Swan GE, et al. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke 1998; 29: 1177-81.
60. Turner ST, Jack CR, Fornage M, et al. Heritability of leukoaraiosis in hypertensive sibships. Hypertension 2004; 43: 483-7.
61. Brickman AM, Siedlecki KL, Muraskin J, et al. White matter hyperintensities and cognition: testing the reserve hypothesis. Neurobiol Aging 2011; 32: 1588-98.
62. Jokinen H, Kalska H, Ylikoski R, et al. Longitudinal cognitive decline in subcortical ischemic vascular diseasedthe LADIS Study. Cerebrovasc Dis 2009; 27: 384-91.
63. Podgorska A, Hier DB, Pytlewski A, et al. Leukoaraiosis and stroke outcome. J Stroke Cerebrovasc Dis 2002; 11: 336-40.
64. Teodorczuk A, Firbank MJ, Pantoni L, et al. Relationship between baseline whitematter changes and development of late-life depressive symptoms: 3-year results from the LADIS study. Psychol Med 2010; 40: 603-10.
65. Baezner H, Blahak C, Poggesi A, et al. Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology 2008; 70: 935-42.
66. Enzinger C, Fazekas F, Ropele S, et al. Progression of cerebral white matter lesionsdclinical and radiological considerations. J Neurol Sci 2007; 257: 5-10.
67. Berger K, Roesler A, Kretzschmar K. The association between white matter lesions, stroke and activities of daily livingdthe MEMO study on the KORA platform Augsburg. Gesundheitswesen 2005; (67 Suppl 1): S172-5.
68. Fu JH, Lu CZ, Hong Z, et al. Extent of white matter lesions is related to acute subcortical infarcts and predicts further stroke risk in patients with first ever ischaemic stroke. J Neurol Neurosurg Psychiatry 2005; 76: 793-6.
69. Schmidt R, Fazekas F, Kapeller P, et al. MRI white matter hyperintensities: threeyear follow-up of the Austrian Stroke Prevention Study. Neurology 1999; 53: 132-9.
70. Taylor WD, MacFall JR, Provenzale JM, et al. Serial MR imaging of volumes of hyperintense white matter lesions in elderly patients: correlation with vascular risk factors. Am J Roentgenol 2003; 181: 571-6.
71. van Dijk EJ, Prins ND, Vermeer SE, et al. C-reactive protein and cerebral smallvessel disease: the Rotterdam Scan Study. Circulation 2005; 112: 900-5.
72. Longstreth WT Jr, Arnold AM, Beauchamp NJ Jr, et al. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 2005; 36: 56-61.
73. Gouw AA, van der Flier WM, Fazekas F, et al. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: The Leukoaraiosis and Disability Study. Stroke 2008; 39: 1414-20.
74. Almkvist O, Wahlund LO, Andersson-Lundman G, et al. White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. Arch Neurol 1992; 49: 626-32.
75. Bronge L, Wahlund LO. Prognostic significance of white matter changes in a memory clinic population. Psychiatry Res 2003; 122: 199-206.
76. Bracco L, Campani D, Baratti E, et al. Relation between MRI features and dementia in cerebrovascular disease patients with leukoaraiosis: a longitudinal study. J Neurol Sci 1993; 120: 131-6.
77. Schmidt R, Schmidt H, Kapeller P, et al. The natural course of MRI white matter hyperintensities. J Neurol Sci 2002; 203-204: 253-7.
78. Whitman GT, Tang Y, Lin A, et al. A prospective study of cerebral white matter abnormalities in older people with gait dysfunction. Neurology 2001; 57: 990-4.
79. Ovbiagele B, Saver JL. Cerebral white matter hyperintensities on MRI: current concepts and therapeutic implications. Cerebrovasc Dis 2006; 22: 83-90.
80. Dufouil C, Chalmers J, Coskun O, et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 2005; 13: 1644-50.
81. ten Dam VH, van den Heuvel DM, van Buchem MA, et al. Effect of pravastatin on cerebral infarcts and white matter lesions. Neurology 2005; 64: 1807-9.
82. Ruland S, Gorelick PB. Are cholesterol-lowering medications and antihypertensive agents preventing stroke in ways other than by controlling the risk factor? Curr Atheroscler Rep 2003; 5: 38-43.
83. Mok VC, Lam WW, Fan YH, et al. Effects of statins on the progression of cerebral white matter lesion: post hoc analysis of the ROCAS (Regression of Cerebral Artery Stenosis) study. J Neurol 2009; 256: 750-7.
84. Aktas B, Utz A, Hoenig-Liedl P, et al. Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies. Stroke 2003; 34: 764-9.
85. Kato H, Izumiyama M, Izumiyama K, et al. Silent cerebral microbleeds on T2*- weighted MRI: correlation with stroke subtype, stroke recurrence, and leukoaraiosis. Stroke 2002; 33: 1536-40.
86. Lee SH, Heo JH, Yoon BW. Effects of microbleeds on hemorrhage development in leukoaraiosis patients. Hypertens Res 2005; 28: 895-9.
87. Palumbo V, Boulanger JM, Hill MD, et al. Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke. Neurology 2007; 68: 1020-4.
88. Neumann-Haefelin T, Hoelig S, Berkefeld J, et al. Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke 2006; 37: 2463-6.
89. Gorter JW; for the Stroke Prevention in Reversible Ischemia Trial (SPIRIT) and European Atrial Fibrillation Trial (EAFT) Study Groups. Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Neurology 1999; 53: 1319-27.
90. Smith EE, Rosand J, Knudsen BA, et al. Leukoaraiosis is associated with warfarinrelated hemorrhage following ischemic stroke: the Cardiovascular Health Study. Neurology 2002; 59: 193-7.